Keyphrases
Phosphoinositide 3-kinase (PI3K)
100%
Mammalian Target of Rapamycin (mTOR)
100%
Fatty Acid Synthase Inhibitor
100%
Ovarian Cancer Cells
100%
Fatty Acid Synthase
88%
Beta-blockers
22%
EGF Receptor
22%
MTORC1 Signaling
22%
MEK-ERK
22%
Micropatterning
11%
Therapeutic Approaches
11%
Phosphorylation
11%
Growth Inhibition
11%
Polyunsaturated Fatty Acids
11%
Thin Layer Chromatography
11%
AKT1
11%
MALDI-MS
11%
Grb2
11%
Ovarian Cancer
11%
SKOV3
11%
Hypoxia-inducible factor-1α (HIF-1α)
11%
RTP801
11%
A2780
11%
Signaling Lipids
11%
ERK Activation
11%
Stress-responsive Genes
11%
Lipid Biosynthesis
11%
P-AMPK
11%
AZD6244
11%
Diacylglycerol
11%
Dactolisib
11%
Targeting Strategies
11%
Pathway Crosstalk
11%
Multiple Levels
11%
Co-target
11%
OVCAR-3
11%
ERK Inhibitor
11%
PIP3
11%
MEK Inhibitor (MEKi)
11%
REDD+
11%
NVP-BEZ235
11%
DDIT4
11%
Western Blotting
11%
Selumetinib
11%
Receptor Recruitment
11%
MS-MS
11%
Biochemistry, Genetics and Molecular Biology
Fatty Acid Synthase
100%
Cancer Cell
100%
Epidermal Growth Factor Receptor
16%
Tandem Mass Spectrometry
8%
Lipogenesis
8%
Thin-Layer Chromatography
8%
MEK Inhibitor
8%
Matrix-Assisted Laser Desorption-Ionization
8%
GRB2
8%
Lipid Signaling
8%
Phosphatidylinositol (3,4,5)-trisphosphate
8%
Growth Inhibition
8%
Western Blot
8%
Polyunsaturated Fatty Acid
8%
Diglyceride
8%
Protein Kinase B
8%